Stents, scaffolds and DCB

This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

To gain insight on managing difficult and unusual coronary conditions, view these cases on: balloons, drills and shocks, a novel technique to manage large multiple mycotic aneurysms, rota-stenosis, left main longitudinal compression and many more!

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

View the replay of this Webinar on the SYNTAX II strategy: integrating best practices in complex PCI, with J. Escaned, J. Hill and F. Ribichini.

Stay up to date with what was new and hot in interventional cardiology at the #ESCCongress 2022!

The results of this study show that at 2-year follow-up HBR patients undergoing PCI with a polymer-based zotarolimus-eluting stent & 1-month DAPT had similar outcomes in terms of both safety & efficacy to those with a polymer-free biolimus A9-coated stent.